|
業務類別
|
Drug Manufacturers - Specialty & Generic |
|
業務概覽
|
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic. |
| 公司地址
| 100 Technology Center Drive, Stoughton, MA, USA, 02072 |
| 電話號碼
| +1 781 713-3699 |
| 傳真號碼
| +1 781 828-4697 |
| 公司網頁
| https://www.collegiumpharma.com |
| 員工數量
| 423 |
| Mr. Vikram Karnani |
Director, President and Chief Executive Officer |
美元 875.00K |
07/04/2026 |
| Ms. Colleen Tupper |
Executive Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 559.34K |
07/04/2026 |
| Mr. Scott Dreyer |
Executive Vice President and Chief Commercial Officer |
美元 523.24K |
07/04/2026 |
| Dr. Thomas B. Smith, M.D. |
Executive Vice President and Chief Medical Officer |
美元 492.96K |
07/04/2026 |
| Mr. David Dieter |
Executive Vice President, General Counsel and Corporate Secretary |
美元 384.62K |
07/04/2026 |
|
|
| Mr. Vikram Karnani |
Director, President and Chief Executive Officer |
07/04/2026 |
| Dr. Rita Balice-Gordon, PhD |
Independent Director |
07/04/2026 |
| Mr. Gino Santini |
Chairman of the Board |
07/04/2026 |
| Dr. John G. Freund,M.D. |
Independent Director |
07/04/2026 |
| Dr. John A. Fallon, M.D. |
Independent Director |
07/04/2026 |
| Mr. Michael Donovan |
Director |
07/04/2026 |
| Ms. Nancy S. Lurker |
Independent Director |
07/04/2026 |
| Mr. Garen G. Bohlin |
Independent Director |
07/04/2026 |
| Dr. Carlos V. Paya,M.D.,PhD |
Independent Director |
07/04/2026 |
|
|
|
|
